Elsevier

Kidney International

Volume 82, Issue 9, 1 November 2012, Pages 952-960
Kidney International

Review
Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s)

https://doi.org/10.1038/ki.2012.270Get rights and content
Under an Elsevier user license
open archive

The Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guideline for anemia in chronic kidney disease (CKD) is designed to assist health-care providers in treating CKD patients with anemia. A guideline is not intended to define a standard of care, and should not be construed as one, nor should it be interpreted as prescribing an exclusive course of management. It is intended to provide information and to allow the practitioner to make an informed decision, based on evidence and expert judgment. Every health-care professional making use of these recommendations is responsible for evaluating the appropriateness of applying them in any particular clinical situation. Owing to the general nature of a guideline, it is sometimes difficult to translate it to an individual patient's condition. As the primary goal is to improve patient care, we have decided to focus on practical clinical aspects of the KDIGO anemia guideline.

Keywords

anemia
CKD
KDIGO guideline
recommendations

Cited by (0)

TBD reports receiving consulting fees and lecture fees from Amgen, Chugai, F. Hoffmann–La Roche, FMC, Pharmacosmos, and Vifor. PSP reports receiving consulting fees and lecture fees from Amgen.

Summary of Recommendation Statement is provided in the Appendix.